Score Overview
Explore the 2021 public Archive ranking →
Where Integra LifeSciences Holdings has ranked, year by year
Showing 1 year ranking history by HDB Score.
Reached the top 50 on HDB Score in 1 year, the longest run being 1 in a row — but not in 2021.
- IART
2001: 80.3% · 2021: 31.5% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-30 | $ 16.28 | — |
1 Year2025-09-30 | $ 14.33 | 13.61% |
5 Years2021-09-30 | $ 68.48 | -76.23% |
10 Years2016-09-30 | $ 41.27 | -60.56% |
20 Years2006-09-29 | $ 13.34 | 22.03% |
30 Years1996-09-30 | $ 4.72 | 245.17% |
All Time1995-08-16 | $ 3.29 | 394.44% |
| Period | Last Price2026-09-30 | 1 Year2025-09-30 | 5 Years2021-09-30 | 10 Years2016-09-30 | 20 Years2006-09-29 | 30 Years1996-09-30 | All Time1995-08-16 |
|---|---|---|---|---|---|---|---|
| Price | $ 16.28 | $ 14.33 | $ 68.48 | $ 41.27 | $ 13.34 | $ 4.72 | $ 3.29 |
| Return | — | 13.61% | -76.23% | -60.56% | 22.03% | 245.17% | 394.44% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 1.64B | -$ 7M | $ 274M |
| 2025 | $ 1.63B | -$ 516M | $ 263M |
| 2024 | $ 1.61B | -$ 6M | $ 273M |
| 2023 | $ 1.54B | $ 67M | $ 309M |
| 2022 | $ 1.55B | $ 180M | $ 456M |
| 2021 | $ 1.54B | $ 169M | $ 513M |
| 2020 | $ 1.37B | $ 133M | $ 470M |
| 2019 | $ 1.51B | $ 50M | $ 198M |
| 2018 | $ 1.47B | $ 60M | $ 138M |
| 2017 | $ 1.18B | $ 64M | $ 174M |
| 2016 | $ 992M | $ 74M | $ 102M |
| 2015 | $ 882M | -$ 3M | $ 48M |
| 2014 | $ 928M | $ 34M | $ 71M |
| 2013 | $ 836M | -$ 16M | $ 120M |
| 2012 | $ 830M | $ 41M | $ 96M |
| 2011 | $ 780M | $ 27M | $ 100M |
| 2010 | $ 732M | $ 65M | $ 128M |
| 2009 | $ 682M | $ 50M | $ 71M |
| 2008 | $ 654M | $ 34M | $ 183M |
| 2007 | $ 550M | $ 33M | $ 57M |
| 2006 | $ 419M | $ 29M | $ 22M |
| 2005 | $ 277M | $ 37M | $ 127M |
| 2004 | $ 229M | $ 17M | $ 100M |
| 2003 | $ 185M | $ 26M | $ 108M |
| 2002 | $ 112M | $ 35M | $ 98M |
| 2001 | $ 93M | $ 26M | $ 66M |
| 2000 | $ 64M | -$ 11M | $ 15M |
| 1999 | $ 42M | -$ 6M | $ 23M |
| 1998 | $ 17M | -$ 12M | $ 5M |
| 1997 | $ 14M | -$ 17M | $ 2M |
| 1996 | $ 13M | -$ 7M | $ 11M |
| IPO1995 | $ 10M | -$ 25M | $ 4M |
Integra LifeSciences Holdings fundamental performance
Between 2005 and 2025, revenue grew from $ 277M to $ 1.63B and net income went from $ 37M to -$ 516M. Revenue increased in 17 of those 20 years; net income in 11.
Across Integra LifeSciences Holdings's full reported history, from 1995 to 2025, revenue grew from $ 10M to $ 1.63B and net income went from -$ 25M to -$ 516M. Revenue increased in 90% of the years measured; net income in 55%.
Integra LifeSciences Holdings currently holds a 20-year HDB Score of 4.8 out of 10. How the HDB Score is calculated.
Membership
Continue IART’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,814 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
